Up-regulation of PPARγ, heat shock protein-27 and-72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes

British Journal of Nutrition

Volumn 106, Issue 11, 2011, Pages 1713-1723

  Sharma, Ashok Kumar ^a   Bharti, Saurabh ^a   Ojha, Shreesh ^a   Bhatia, Jagriti ^a   Kumar, Narender ^a   Ray, Ruma ^a   Kumari, Santosh ^b   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN AGRICULTURAL RESEARCH INSTITUTE   (India)

Author keywords

Heat shock proteins; Insulin resistance; Naringin; PPAR ; Type 2 diabetes

Indexed keywords

ADIPONECTIN; AURANTIIN; C REACTIVE PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 72; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY LIVER; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; KIDNEY; KIDNEY INJURY; LIPID DIET; LIVER; LIVER CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY LIVER; FLAVANONES; HSP27 HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; PPAR GAMMA; RATS; RATS, WISTAR; UP-REGULATION;

EID: 82255195245     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451100225X     Document Type: Article

References (35)

1. Shaw JE, Sicree RA & Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4-14.
2. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444, 860-867. (Pubitemid 46024993)
3. Wellen KE & Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119. (Pubitemid 40629025)
4. Koning EJ, Bonner-Weir S & Rabelink TJ (2008) Preservation of beta-cell function by targeting beta-cell mass. Trends Pharmacol Sci 29, 218-227.
5. Mulvihill EE, Allister EM, Sutherland BG, et al. (2009) Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced IR. Diabetes 58, 2198-2210.
6. Furukawa S, Fujita T, Shimabukuro M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761. (Pubitemid 40385531)
7. Goldberg RB, Holman R & Drucker DJ (2008) Management of type 2 diabetes. N Engl J Med 358, 293-297.
8. Nahas R & Moher M (2009) Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 55, 591-596.
9. Jeon SM, Park YB & Choi MS (2004) Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin Nutr 23, 1025-1034. (Pubitemid 39243016)
10. Kim HJ, Oh GT, Park YB, et al. (2004) Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. Life Sci 74, 1621-1634. (Pubitemid 38114792)
11. Jung UJ, Lee MK, Park YB, et al. (2006) Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 38, 1134-1145.
12. Aggarwal A, Gaur V & Kumar A (2010) Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice. Life Sci 86, 928-935.
13. Michalik L & Wahli W (2006) Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 116, 598-606. (Pubitemid 43326864)
14. Yki-Jarvinen H (2004) Thiazolidinediones. N Engl J Med 351, 1106-1118.
15. Chung J, Nguyen AK, Henstridge DC, et al. (2008) HSP72 protects against obesity-induced IR. Proc Natl Acad Sci USA 105, 1739-1744.
16. Meldrum KK, Burnett AL, Meng X, et al. (2003) Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 92, 293-299. (Pubitemid 36258551)
17. Garrido C, Bruey JM, Fromentin A, et al. (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13, 2061-2070. (Pubitemid 29517636)
18. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: IR and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
19. Ohkawa H, Oohishi N & Yagi N (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358. (Pubitemid 9194347)
20. Marklund S & Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47, 469-474.
21. Lawrence RA & Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71, 952-958.
22. Bradford MM (1976) A rapid and sensitive method for quantization of microgram quantities effects of age and caloric restriction. Anal Biochem 72, 248-254.
23. Jang A, Srinivasan P, Lee NY, et al. (2008) Comparison of hypolipidemic activity of synthetic gallic acid-linoleic acid ester with mixture of gallic acid and linoleic acid, gallic acid, and linoleic acid on high-fat diet induced obesity in C57BL/6Cr Slc mice. Chem Biol Interact 174, 109-117.
24. Danda RS, Habiba NM, Rincon-Choles H, et al. (2005) Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 68, 2562-2571. (Pubitemid 43251001)
25. Srinivasan K, Viswanad B, Asrat L, et al. (2005) Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52, 313-320. (Pubitemid 41175991)
26. Parveen K, Khan MR, Mujeeb M, et al. (2010) Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 186, 219-227.
27. Serisier S, Leray V, Poudroux W, et al. (2008) Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs. Br J Nutr 99, 1208-1216.
28. Morimoto RI (1993) Cells in stress: transcriptional activation of heat shock genes. Science 259, 1409-1410. (Pubitemid 23101373)
29. Martins de Lima-Salgado T, Coccuzzo Sampaio S, Fernanda Cury-Boaventura M, et al. (2011) Modulatory effect of fatty acids on fungicidal activity, respiratory burst and TNF-a and IL-6 production in J774 murine macrophages. Br J Nutr 14, 1-7.
30. Van den Berg R, Haenen GR, Van den Berg H, et al. (2001) Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr 86, Suppl. 1, S121-S127. (Pubitemid 32916187)
31. Taniguchi CM, Ueki K & Kahn R (2005) Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest 115, 718-727. (Pubitemid 40322247)
32. Ceriello A & Motz E (2004) Is oxidative stress the pathogenic mechanism underlying IR, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24, 816-823. (Pubitemid 38620857)
33. Taskinen MR (2003) Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 46, 733-749.
34. Alvarez-González I, Madrigal-Bujaidar E, Dorado V, et al. (2001) Inhibitory effect of naringin on the micronuclei induced by ifosfamide in mouse, and evaluation of its modulatory effect on the Cyp3a subfamily. Mutat Res 480-481, 171-178. (Pubitemid 32744825)
35. Lambev I, Krushkov I, Zheliazkov D, et al. (1980) Antiexudative effect of naringin in experimental pulmonary edema and peritonitis. Eksp Med Morfol 19, 207-212. (Pubitemid 11161360)